Business News • PR NewsWire • Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture |
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture |
|
|
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture
SINGAPORE, June 25, 2021 /PRNewswire/ -- CYFIRMA, a threat discovery and cyber-intelligence platform company, funded by Goldman Sachs, Zodius Capital and Z3Partners, today announced that Zuellig Pharma, a leading healthcare services provider in Asia, has selected DeCYFIR, a cloud-based,...
View More : https://www.prnewswire.com:443/news-releases/zuellig-pharma-selects-cyfirma-to-elevate-cyber-intelligence-capabilities-a...
|
|
|